These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Charge reversal self-emulsifying drug delivery systems: A comparative study among various phosphorylated surfactants. Akkuş-Dağdeviren ZB; Wolf JD; Kurpiers M; Shahzadi I; Steinbring C; Bernkop-Schnürch A J Colloid Interface Sci; 2021 May; 589():532-544. PubMed ID: 33493863 [TBL] [Abstract][Full Text] [Related]
3. Design of nanostructured lipid carriers and solid lipid nanoparticles for enhanced cellular uptake. Veider F; Akkuş-Dağdeviren ZB; Knoll P; Bernkop-Schnürch A Int J Pharm; 2022 Aug; 624():122014. PubMed ID: 35850184 [TBL] [Abstract][Full Text] [Related]
4. Digestion of lipid excipients and lipid-based nanocarriers by pancreatic lipase and pancreatin. Zöller K; To D; Knoll P; Bernkop-Schnürch A Eur J Pharm Biopharm; 2022 Jul; 176():32-42. PubMed ID: 35584719 [TBL] [Abstract][Full Text] [Related]
9. Overcoming intestinal barriers by heparanase-responsive charge-converting nanocarriers. Veider F; Zöller K; Saleh A; Bernkop-Schnürch A Int J Pharm; 2024 Feb; 651():123817. PubMed ID: 38237708 [TBL] [Abstract][Full Text] [Related]
10. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122 [TBL] [Abstract][Full Text] [Related]
11. Size shifting of solid lipid nanoparticle system triggered by alkaline phosphatase for site specific mucosal drug delivery. Le-Vinh B; Steinbring C; Wibel R; Friedl JD; Bernkop-Schnürch A Eur J Pharm Biopharm; 2021 Jun; 163():109-119. PubMed ID: 33775852 [TBL] [Abstract][Full Text] [Related]
12. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation. Suchaoin W; Pereira de Sousa I; Netsomboon K; Lam HT; Laffleur F; Bernkop-Schnürch A Int J Pharm; 2016 Aug; 510(1):255-62. PubMed ID: 27329673 [TBL] [Abstract][Full Text] [Related]
13. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam. Dasgupta S; Ray S; Dey S; Pal P; Mazumder B Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909 [TBL] [Abstract][Full Text] [Related]
14. Zeta Potential Changing Polyphosphate Nanoparticles: A Promising Approach To Overcome the Mucus and Epithelial Barrier. Akkus ZB; Nazir I; Jalil A; Tribus M; Bernkop-Schnürch A Mol Pharm; 2019 Jun; 16(6):2817-2825. PubMed ID: 31070926 [TBL] [Abstract][Full Text] [Related]
15. Development of lipid nanoparticles for transdermal loteprednol etabonate delivery. Üner B; Özdemir S; Taş Ç; Özsoy Y; Üner M J Microencapsul; 2022 Jun; 39(4):327-340. PubMed ID: 35583383 [TBL] [Abstract][Full Text] [Related]
16. Combination of SEDDS and Preactivated Thiomer Technology: Incorporation of a Preactivated Thiolated Amphiphilic Polymer into Self-Emulsifying Delivery Systems. Hetényi G; Griesser J; Nardin I; Bernkop-Schnürch A Pharm Res; 2017 Jun; 34(6):1171-1179. PubMed ID: 28283859 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933 [TBL] [Abstract][Full Text] [Related]
18. Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating. Griesser J; Hetényi G; Kadas H; Demarne F; Jannin V; Bernkop-Schnürch A Int J Pharm; 2018 Mar; 538(1-2):159-166. PubMed ID: 29339247 [TBL] [Abstract][Full Text] [Related]